Home LiteratureArticle Details
PMID: 6090218 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Modelling the ATP-binding site of oncogene products, the epidermal growth factor receptor and related proteins.

FEBS letters ·Vol. 175 ·No. 2 ·1984-10-01 ·Pages 387-92

Sternberg MJ, Taylor WR

Abstract

A three-dimensional model for the ATP-binding site of the oncogene product v-src is proposed by the use of interactive computer graphics. A similar model would apply to sequence related proteins such as other oncogene products, the epidermal growth factor receptor, cAMP-dependent protein kinase and the cell division control protein CDC28. The model was proposed on the basis of the conservation of certain key residues between the oncogene product family of proteins and several nucleotide binding proteins of known structures.

MeSH Terms
Adenosine Triphosphate/metabolism Amino Acid Sequence Animals Binding Sites Enzymes/metabolism Epidermal Growth Factor/metabolism ErbB Receptors Glucosephosphate Dehydrogenase/metabolism Models, Molecular NAD/metabolism Oncogene Protein pp60(v-src) Oncogenes Protein Binding Protein Conformation Protein Kinases/metabolism Receptors, Cell Surface/metabolism Viral Proteins/metabolism
Chemicals
Enzymes Receptors, Cell Surface Viral Proteins NAD Epidermal Growth Factor Adenosine Triphosphate Glucosephosphate Dehydrogenase Protein Kinases ErbB Receptors Oncogene Protein pp60(v-src)
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Sternberg M J
Taylor W R
Article Info
Journal
FEBS letters
Abbr.
FEBS Lett
ISSN
0014-5793
Published
1984-10-01
Pages
387-92
Language
English
Region
England
NLM ID
0155157
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]